Researchers have identified the SHP protein as a key regulator that suppresses cartilage-degrading enzymes and slows osteoarthritis progression.

Complete response (CR) observed in 70% (50/72) of evaluable patients with low-grade upper tract urothelial cancer (UTUC) who ...

A major report highlighting how engineering biology can drive economic growth, improved health outcomes and environmental ...

This clinical-stage biotech develops bifunctional antibody therapies targeting solid tumors for oncology providers and ...